FUTURELYTICS Trademark

Trademark Overview


On Wednesday, June 17, 2015, a trademark application was filed for FUTURELYTICS with the United States Patent and Trademark Office. The USPTO has given the FUTURELYTICS trademark a serial number of 86666115. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 20, 2019. This trademark is owned by Roche Molecular Systems, Inc.. The FUTURELYTICS trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software

Data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of ...
futurelytics

General Information


Serial Number86666115
Word MarkFUTURELYTICS
Filing DateWednesday, June 17, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 20, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2016

Trademark Statements


Goods and ServicesDownloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software
Goods and ServicesData collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, providing scientific information on individuals' genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing an on-line searchable database in the field of clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information and biomarker information for scientific research purposes
Pseudo MarkFUTURE LYTICS

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, June 23, 2015
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 23, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoche Molecular Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Party NameRoche Molecular Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Trademark Events


Event DateEvent Description
Monday, May 20, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 20, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, October 22, 2018EXTENSION 5 GRANTED
Thursday, October 11, 2018EXTENSION 5 FILED
Thursday, October 18, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 11, 2018TEAS EXTENSION RECEIVED
Friday, March 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, March 7, 2018EXTENSION 4 GRANTED
Wednesday, March 7, 2018EXTENSION 4 FILED
Wednesday, March 7, 2018TEAS EXTENSION RECEIVED
Wednesday, October 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, October 16, 2017EXTENSION 3 GRANTED
Monday, October 16, 2017EXTENSION 3 FILED
Monday, October 16, 2017TEAS EXTENSION RECEIVED
Wednesday, April 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, April 17, 2017EXTENSION 2 GRANTED
Monday, April 17, 2017EXTENSION 2 FILED
Monday, April 17, 2017TEAS EXTENSION RECEIVED
Friday, October 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, October 12, 2016EXTENSION 1 GRANTED
Wednesday, October 12, 2016EXTENSION 1 FILED
Wednesday, October 12, 2016TEAS EXTENSION RECEIVED
Tuesday, April 19, 2016NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 23, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2016NOTICE OF PUBLICATION
Wednesday, January 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 14, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 13, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 13, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 3, 2015NON-FINAL ACTION MAILED
Wednesday, September 2, 2015NON-FINAL ACTION WRITTEN
Monday, August 31, 2015ASSIGNED TO EXAMINER
Wednesday, June 24, 2015NOTICE OF PSEUDO MARK MAILED
Tuesday, June 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 20, 2015NEW APPLICATION ENTERED IN TRAM